Eiki Takahashi

Dr. Eiki Takahashi

Shanghai Jiaotong University, Shanghai, China
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in Brain Research
Verified
Journal Article
Closed access
ETEiki Takahashi
Eiki Takahashi
KNKimie Niimi
Kimie Niimi
CIChitoshi Itakura
Chitoshi Itakura

1 July 2008 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ETEiki Takahashi
Eiki Takahashi
MKMariko Katayama
Mariko Katayama
KNKimie Niimi
Kimie Niimi
CIChitoshi Itakura
Chitoshi Itakura

30 September 2008 in Experimental Gerontology
Verified
Journal Article
Closed access
KNKimie Niimi
Kimie Niimi
ETEiki Takahashi
Eiki Takahashi
CIChitoshi Itakura
Chitoshi Itakura

1 January 2013 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
ENErika Nakashima
Erika Nakashima
YOYasushi Okano
Yasushi Okano
KNKimie Niimi
Kimie Niimi
ETEiki Takahashi
Eiki Takahashi
The common marmoset (Callithrix jacchus) is used as a non-human primate laboratory animal. Marmoset wasting syndrome (MWS) is a disease endemic to captive colonies, and the pathogenesis is unclear. In the present study, marmosets with chronic bloody high-viscosity diarrhea, which is a contributing factor to MWS, were evaluated, and inflammation in the colon was found. Calprotectin is a surrogate marker of intestinal inflammation and induces apoptosis. Marmosets with chronic diarrhea exhibited higher levels of fecal calprotectin. Histochemical analyses showed high expression of calprotectin in the extravascular neutrophils and apoptosis in the chronic colitis lesions. No internal microbiological diseases were identified. Although the cause of chronic colitis was not identified, the marmoset could be a useful model of inflammatory bowel disease.

1 March 2017 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
NSNatsuko Saito
Natsuko Saito
SKShunsuke Kimura
Shunsuke Kimura
TMTomomi Miyamoto
Tomomi Miyamoto
SFSanae Fukushima
Sanae Fukushima
MAMisato Amagasa
Misato Amagasa
HKHiroshi Kitamura
Hiroshi Kitamura
We previously reported that ubiquitin-specific protease (USP) 2 in macrophages down-regulates genes associated with metabolic diseases, suggesting a putative anti-diabetic role for USP2 in macrophages. In this study, we evaluate this role at both cellular and individual levels. Isolated macrophages forcibly expressing Usp2a, a longer splicing variant of USP2, failed to modulate the insulin sensitivity of 3T3-L1 adipocytes. Similarly, macrophage-selective overexpression of Usp2a in mice (Usp2a transgenic mice) had a negligible effect on insulin sensitivity relative to wild type littermates following a three-month high-fat diet. However, Usp2a transgenic mice exhibited fewer M1 macrophages in their mesenteric adipose tissue. Following a six-month high-fat diet, Usp2a transgenic mice exhibited a retarded progression of insulin resistance in their skeletal muscle and liver, and an improvement in insulin sensitivity at an individual level. Although conditioned media from Usp2a-overexpressing macrophages did not directly affect the insulin sensitivity of C2C12 myotubes compared to media from control macrophages, they did increase the insulin sensitivity of C2C12 cells after subsequent conditioning with 3T3-L1 cells. These results indicate that macrophage USP2A hampers obesity-elicited insulin resistance via an adipocyte-dependent mechanism.

1 July 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
TKTae Yeon Kim
Tae Yeon Kim
TMTakehiro Maki
Takehiro Maki
YZYing Zhou
Ying Zhou
KSKeita Sakai
Keita Sakai
YMYuri Mizuno
Yuri Mizuno
ETEiki Takahashi
Eiki Takahashi